뉴스

China fast-tracks innovative homegrown drugs as global partnerships grow

China's innovative drug industry is now expanding rapidly, with regulators approving 19 of these drugs so far this year alone. This includes 15 that were developed in China, while overseas licensing deals exceeded $60 billion in the first quarter, according to official data.

Never alone in times of crisis: HK and mainland stand in solidarity to aid rescue and relief in high-rise fire